CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 990 enrolled
Drug / intervention
Telecardiology programdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02068118
NCT02068118N/ACompleted

Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)

CDM e-Health·interventional·Posted Feb 21, 2014·Updated Oct 26, 2021

In Brief

A clinical study evaluating Telecardiology program for Chronic Heart Failure. Completed, enrolled 990 participants across 38 sites in 2 countries.

Detailed Summary

Targeted population: Patients with heart failure causing hospitalization during the last twelve months. Hypothesis: The number of all cause deaths and hospitalizations will be smaller for the Telecardiology group than for the reference group (standard follow-up care). An 18 months period of observation is required. Main goal: To compare the rate of all cause deaths and hospitalizations of patients with heart failure between the Telecardiology group and the reference group after 18 months of monitoring.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Martinique
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 21, 2014
Enrollment StartMay 1, 2013
Primary CompletionDec 20, 2017
Study CompletionSep 28, 2018
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 12.4 years ago

Interventions

Telecardiology programdevice

The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses. Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.